CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Moberg Pharma AB (publ) Company Snapshot
Moberg Pharma AB (publ) operates in the Medicinals and botanicals sector. In addition to historical fundamental analyses, the complete report available to purchase compares Moberg Pharma AB (publ) with three other pharmaceutical manufacturers in Europe: Horizon Discovery Group PLC of the United Kingdom (2017 sales of £36.51 million [US$46.51 million] of which 62% was Products), Venture Life Group plc of the United Kingdom (£16.05 million [US$20.45 million] ), and Lavipharm SA which is based in Greece (31.81 million Euro [US$36.06 million] ).

Sales Analysis. Moberg Pharma AB (publ) reported sales of SEK 439.03 million (US$48.89 million) for the year ending December of 2017. This represents an increase of 31.3% versus 2016, when the company's sales were SEK 334.30 million. Sales at Moberg Pharma AB (publ) have increased during each of the previous five years (and since 2012, sales have increased a total of 290%). Sales of Divested Products (Jointflex , Fergon , saw an increase that was more than double the company's growth rate: sales were up 115.2% in 2017, from SEK 16.32 million to SEK 35.12 million. Not all segments of Moberg Pharma AB (publ) experienced an increase in sales in 2017: sales of Other Products fell 19.8% to SEK 65.85 million.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Moberg Pharma AB (publ)
  Stock Performance Chart for Moberg Pharma AB (publ)
 
  Stock Data: Recent Stock Performance:
  Current Price (12/7/2018): 43.05
(Figures in Swedish Kronor)
1 Week -4.9%   13 Weeks -13.8%  
4 Weeks -18.8%   52 Weeks 45.4%  
 
Moberg Pharma AB (publ) Key Data:
  Ticker: MOB Country: Sweden
  Exchanges: STO Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Medicinals & Botanicals
  2017 Sales 439,032,000
(Year Ending Jan 2018).
Employees: 40
  Currency: Swedish Kronor Market Cap: 762,146,954
  Fiscal Yr Ends: December Shares Outstanding: 17,703,762
  Share Type: Aktie Closely Held Shares: 7,646,360
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.